Page 30 of 105
Previous Page     Next Page        Smaller fonts | Larger fonts     Go back to the flash version

MagForce AG (Frankfurt, XETRA: MF6), the leading medical device company in the field of nanomedicine with focus on oncology, announced that Jan zur Hausen was unanimously elected to the company's Supervisory Board. Jan zur Hausen is a managing shareholder of Bergmann zur Hausen & Cie. GmbH, a corporate finance company that evolved from Sal. Oppenheim‘s investment banking activities.

http://www.magforce.de

MAPPER Lithography announced the signing of a deal for a financing round of EUR80 million. The round is led by RUSNANO (EUR40 m). Another EUR40 million will be contributed by current share- holders like ADP Industries, the investment vehicle of Mr. Arthur Del Prado, investment firm Parcom Capital (Parc-IT), Hoving & Partners along with Dutch high-end technology suppliers such as Technolution and DEMCON and innovation credits from AgentschapNL. Also other parties such as a number of Dutch individuals and family investment offices will contribute to the total amount. MAPPER MAPPER Lithography, founded out of Delft University of Technology, is a Delft-based company focusing on maskless e-beam direct-write lithography.

http://www.mapperlithography.com

MicroVision, Inc.(NASDAQ:MVIS), a leader in innovative ultra-miniature projection display technology, announced its operating and financial results for the second quarter of 2012 and the advan- cement of its 2012 business objectives. During the second quarter, MicroVision received purchase orders totaling $4.4 million from Pioneer Corporation in support of its Cyber Navi car navi- gation system, which began shipping in July 2012. MicroVision began deliveries in the second quarter and expects to increase volume and revenue in the second half of 2012. In July, the company received $1.4 million in additional purchase orders for PicoP Gen 2 components from Pioneer Corporation scheduled for delivery in 2013, bringing the total orders to $5.8 million. During the quarter the company raised $14.6 million net of issuance cost through equity offerings. The following financial results are for three and six months ended June 30, 2012, compared to the same periods one year earlier. Revenue was $1.3 million for the second quarter of 2012, compared to $1.2 million for the second quarter of 2011, and $3.0 million for the first half of 2012, compared to $2.3 million for the first half one year ago. Backlog was $5.4 million as of June 30, 2012. Net loss was $5.0 million, or $0.26 per share, for the quarter, compared to $9.2 million, or $0.69 per share, for the same quarter a year ago. Net loss was $14.8, or $0.82 per share, for the first half of 2012, compared to $18.2 million, or $1.39 per share, for the first half of 2011. As of June 30, 2012, cash and cash equivalents were $14.8 million.

http://www.microvision.com

 

Previous arrowPrevious Page     Next PageNext arrow        Smaller fonts | Larger fonts     Go back to the flash version
1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  |  9  |  10  |  11  |  12  |  13  |  14  |  15  |  16  |  17  |  18  |  19  |  20  |  21  |  22  |  23  |  24  |  25  |  26  |  27  |  28  |  29  |  30  |  31  |  32  |  33  |  34  |  35  |  36  |  37  |  38  |  39  |  40  |  41  |  42  |  43  |  44  |  45  |  46  |  47  |  48  |  49  |  50  |  51  |  52  |  53  |  54  |  55  |  56  |  57  |  58  |  59  |  60  |  61  |  62  |  63  |  64  |  65  |  66  |  67  |  68  |  69  |  70  |  71  |  72  |  73  |  74  |  75  |  76  |  77  |  78  |  79  |  80  |  81  |  82  |  83  |  84  |  85  |  86  |  87  |  88  |  89  |  90  |  91  |  92  |  93  |  94  |  95  |  96  |  97  |  98  |  99  |  100  |  101  |  102  |  103  |  104  |  105